Buffalo, NY (November 15, 2021) — CSSHealth today announced the addition of a configurable telehealth module to its signature MTMPathTM software, offering pharmacists a low-overhead healthcare delivery option with potentially significant, positive implications for patient medication management and adherence.  When asked about the potential of telehealth to improve adherence Jim Notaro, RPh, PhD, CSSHealth Chief Clinical Officer, commented “The literature is beginning to demonstrate the efficacy of synchronous audio and video telehealth communication in changing medication use behaviors such as adherence.  In September I blogged on a study which demonstrated the value of telehealth in improving adherence (https://csshealth.com/telehealth-for-medication-adherence/).”  “However”, Notaro continued, “I think health plans and others who are interested in improved adherence still need to understand if the academic results can be translated into practice.”  

To better understand the value of telehealth in practice, CSS Health is offering a six-month telehealth pilot program.  CSS will provide health plan, pharmacy group, and integrated care delivery systems users of MTMPathTM no cost access to the telehealth module to be used in an evaluable adherence initiative.